Posts tagged ‘drug discovery’

In our efforts to bring exposure to rare disease research through our Rare Disease Challenge, we’ve learned that only about 5% of the rare diseases...

Scientist’s CEO, Kevin Lustig, spoke in a recent episode of the Burrill Report about the Open Science movement and how the democratization of drug...

In James Surowiecki’s book “The Wisdom of Crowds”, he lays out the criteria for successful decision making by large groups1: Diversity of opinion...

“Open source”, a term synonymous to computer programming, is a pragmatic methodology that promotes redistribution and access to an end product. In...

Animal testing is critical to advancing science and learning more about disease, but what animals are effective? It’s safe to say that mice, rats...

As pharmaceutical and biotech research becomes more externalized, it is becoming increasingly important to know who is doing your research. Some...

The price of pharmaceutical drugs has been an issue of national debate for decades. As many blockbuster drugs face patent expiration in a few years...

There has been a lot of buzz about single-person drug companies running out of their own homes after a recent NPR report. Overseeing the whole drug...

When we at Scientist say that we help with pharmaceutical outsourcing, what types of services are we helping CROs deliver to researchers? Our site...

Outsourcing? Many people cringe at the sound of the word, but in the drug discovery industry, it’s the future as pharma companies race to cut costs...